Literature DB >> 9770722

Different bile acids exhibit distinct biological effects: the tumor promoter deoxycholic acid induces apoptosis and the chemopreventive agent ursodeoxycholic acid inhibits cell proliferation.

J D Martinez1, E D Stratagoules, J M LaRue, A A Powell, P R Gause, M T Craven, C M Payne, M B Powell, E W Gerner, D L Earnest.   

Abstract

Epidemiological studies have suggested that the concentration and composition of fecal bile acids are important determining factors in the etiology of colon cancer. However, the mechanism by which these compounds influence tumor development is not understood. To begin to elucidate their mechanism of action, four bile acids, cholic acid, chenodeoxycholic acid, deoxycholic acid (DCA), and ursodeoxycholic acid, were examined for their effects on the growth of several different tumor cell lines. We found that incubating cells with chenodeoxycholic acid or DCA caused morphological changes, seen by electron and light microscopy, that were characteristic of apoptosis, whereas incubating cells with ursodeoxycholic acid inhibited cell proliferation but did not induce apoptosis. Cholic acid had no discernible effect on cells. Notably, the apoptosis induced by DCA could be suppressed by inhibiting protein kinase C activity with calphostin C. These results indicate that different bile acids exhibit distinct biological activities and suggest that the cytotoxicity reported for DCA may be due to its capacity to induce apoptosis via a protein kinase C-dependent signaling pathway.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9770722     DOI: 10.1080/01635589809514689

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  47 in total

Review 1.  The management of primary sclerosing cholangitis.

Authors:  Roger W Chapman
Journal:  Curr Gastroenterol Rep       Date:  2003-02

Review 2.  Primary sclerosing cholangitis: is any treatment worthwhile?

Authors:  Ashley Barnabas; Roger W Chapman
Journal:  Curr Gastroenterol Rep       Date:  2012-02

3.  Bile salts increase epithelial cell proliferation through HuR-induced c-Myc expression.

Authors:  Erin E Perrone; Lan Liu; Douglas J Turner; Eric D Strauch
Journal:  J Surg Res       Date:  2012-05-10       Impact factor: 2.192

4.  Matrix metalloproteinase-7-catalyzed release of HB-EGF mediates deoxycholyltaurine-induced proliferation of a human colon cancer cell line.

Authors:  Kunrong Cheng; Guofeng Xie; Jean-Pierre Raufman
Journal:  Biochem Pharmacol       Date:  2006-12-10       Impact factor: 5.858

5.  Akt-dependent NF-kappaB activation is required for bile acids to rescue colon cancer cells from stress-induced apoptosis.

Authors:  Jasleen Shant; Kunrong Cheng; Bernard S Marasa; Jian-Ying Wang; Jean-Pierre Raufman
Journal:  Exp Cell Res       Date:  2008-11-20       Impact factor: 3.905

6.  Dietary bile acid supplementation improves intestinal integrity and survival in a murine model.

Authors:  Erin E Perrone; Chen Chen; Shannon W Longshore; Oneybuchi Okezie; Brad W Warner; Chen-Chih Sun; Samuel M Alaish; Eric D Strauch
Journal:  J Pediatr Surg       Date:  2010-06       Impact factor: 2.545

7.  Deoxycholic acid inhibited proliferation and induced apoptosis and necrosis by regulating the activity of transcription factors in rat pancreatic acinar cell line AR42J.

Authors:  Guixin Zhang; Jingwen Zhang; Dong Shang; Bing Qi; Hailong Chen
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-05-20       Impact factor: 2.416

8.  Growth suppression by ursodeoxycholic acid involves caveolin-1 enhanced degradation of EGFR.

Authors:  Rebecca Feldman; Jesse D Martinez
Journal:  Biochim Biophys Acta       Date:  2009-05-13

9.  Effects of bile acids on proliferation and ultrastructural alteration of pancreatic cancer cell lines.

Authors:  Zheng Wu; Yi Lü; Bo Wang; Chang Liu; Zuo-Ren Wang
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

10.  Deoxycholate induces COX-2 expression via Erk1/2-, p38-MAPK and AP-1-dependent mechanisms in esophageal cancer cells.

Authors:  Eileen Looby; Mohamed M M Abdel-Latif; Veronica Athié-Morales; Shane Duggan; Aideen Long; Dermot Kelleher
Journal:  BMC Cancer       Date:  2009-06-17       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.